Minervax Aps

Calculating rank

USPTO Granted Patents = 5

EPO Patents = 1

Forward Citations = 5

Loading Chart...

2 inventors (with patents filed for the assignee):

Per Bo Pedersen Fischer (4 out of 4 patents)

Gunnar Lindahl (1 out of 7 patents)

5 patents: Sort by Forward Citations

1. 12173033 - Immunogenic fusion protein (2024-12-24),

2. 11484584 - Immunogenic complex for eliciting protective immunity against group B (2022-11-01),

3. 11325950 - Immunogenic fusion protein (2022-05-10),

4. 10888610 - Immunogenic complex for eliciting protective immunity against group b streptococcus (2021-01-12),

5. 8313748 - Fusion protein vaccine (2012-11-20),

Company Overview

Minervax Aps is a biotechnology company focused on developing novel vaccines for infectious diseases. Our dedication to innovation and scientific excellence drives us to create safe and effective solutions to global health challenges. With a team of experienced researchers and collaborators, we are committed to improving public health through the development of cutting-edge vaccines.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#56 in Copenhagen

#471 in Denmark

Copenhagen, Denmark

Minervax Aps

Forward Citations = 5

2 inventors:

Per Bo Pedersen Fischer (4 out of 4 patents)

Gunnar Lindahl (1 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Minervax Aps. Retrieved from https://idiyas.com/company/minervax-aps

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]